Compugen Ltd at JMP Securities Hematology Oncology Summit (Virtual) Transcript
Excellent. Good morning, everyone, and welcome to the Hematology and Oncology Summit here at JMP Securities. It's my pleasure to introduce the Compugen team. Presenting for the Company is Anat, CEO. Eran is here as well. Welcome, team. Great to talk with you.
For those in the audience that may not know, Compugen would love for you to level set the playing field for us, maybe spend two to four minutes and give us an overview of Compugen. And operator, if you can go up about two slides, that would be great.
Sure. Thank you, Reni, for inviting us for this conference. And I'll start with an overview. Compugen is a therapeutic discovery and development company. We discover new drug targets, and we develop first-in-class drugs to address these drug targets. And we're basing our discovery capabilities based on the computational discovery platform that we developed in the company, excelling in this process.
We discovered PVRIG
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |